vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1459Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWКЛИНИКА, ДИФФЕРЕНЦИАЛЬНАЯ ДИАГНОСТИКА И ЛЕЧЕНИЕ ГАЛАКТОЗЕМИИ У ДЕТЕЙCLINIC, DIFFERENTIAL DIAGNOSIS AND TREATMENT OF GALACTOSEMIAЖурковаН.В.ZhurkovaN.V.КондаковаО.Б.KondakovaO.B.БушуеваТ.В.BushuevaT.V.РыбаковаЕ.П.RybakovaE.P.БоровикТ.Э.BorovikT.E.Научный центр здоровья детей РАМН, МоскваРоссияScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowRussian Federation20080511201575Вопросы современной педиатрии7174Copyright © Журкова Н., Кондакова О., Бушуева Т., Рыбакова Е., Боровик Т., 20082008Журкова Н., Кондакова О., Бушуева Т., Рыбакова Е., Боровик Т.Zhurkova N., Kondakova O., Bushueva T., Rybakova E., Borovik T.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1459ReferencesЗахарова Е.Ю., Воскобоева Е.Ю., Байдакова Г.В. Галактоземия, тип 1: клинические проявления, диагностика и лечение. В кн.: Молекулярно–биологические технологии в медицинской практике. Новосибирск: Альфа Виста. 2006. С. 155–160.Захарова Е.Ю., Воскобоева Е.Ю., Байдакова Г.В. Галактоземия, тип 1: клинические проявления, диагностика и лечение. В кн.: Молекулярно–биологические технологии в медицинской практике. Новосибирск: Альфа Виста. 2006. С. 155–160.Новиков В.П., Ходунова А.А., Денисова С.Н. Галактоземия у детей: распространенность, клинико-генетическая гетерогенность, способы диагностики и лечения. Вопросы детской диетологии. 2006; 4 (6): 53–65.Новиков В.П., Ходунова А.А., Денисова С.Н. Галактоземия у детей: распространенность, клинико-генетическая гетерогенность, способы диагностики и лечения. Вопросы детской диетологии. 2006; 4 (6): 53–65.Antshel K., Epstein I., Waisbren S.Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study. Neuropsychology. 2004; 18 (4): 658–664.Antshel K., Epstein I., Waisbren S.Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study. Neuropsychology. 2004; 18 (4): 658–664.Arn P. Galactosemia. Curr. Treat. Options. Neurol. 2003; 5 (4): 343–345.Arn P. Galactosemia. Curr. Treat. Options. Neurol. 2003; 5 (4): 343–345.Bosch A. Classical galactosaemia revisited. J. Inherit. Metab. Dis. 2000; 11: 434–440.Bosch A. Classical galactosaemia revisited. J. Inherit. Metab. Dis. 2000; 11: 434–440.Bosch A., Bakker H., van Gennip A. et al. Clinical features of galactokinase deficiency: a review of the literature. J. Inherit. Metab. Dis. 2002; 25 (8): 6299634.Bosch A., Bakker H., van Gennip A. et al. Clinical features of galactokinase deficiency: a review of the literature. J. Inherit. Metab. Dis. 2002; 25 (8): 6299634.Garden A., Davidson D. Recommendations for the management of galactosaemia. Arch. Dis. Child. 2000; 82 (3): 266.Garden A., Davidson D. Recommendations for the management of galactosaemia. Arch. Dis. Child. 2000; 82 (3): 266.Holton J., Walter J., Tyfield L. et al. The Metabolic and Molecular Bases of Inherited Disease New York: McGraw–Hill. 2001. Vol. II. P. 2297–2326.Holton J., Walter J., Tyfield L. et al. The Metabolic and Molecular Bases of Inherited Disease New York: McGraw–Hill. 2001. Vol. II. P. 2297–2326.Hunter M., Heyer E., Austerlitz F. The P28T mutation in the GALK1 gene accounts for galactokinase deficiency in Roma (Gypsy) patients across Europe. Pediatr. Res. 2002; 51 (5): 602–606.Hunter M., Heyer E., Austerlitz F. The P28T mutation in the GALK1 gene accounts for galactokinase deficiency in Roma (Gypsy) patients across Europe. Pediatr. Res. 2002; 51 (5): 602–606.Maceratesi P., Daude N., Dallapiccola B. et al. Human UDP9galactose 49prime epimerase (GALE) gene and identification of five missense mutations in patients with epimerase9deficiency galactosemia. Molec. Genet. Metab. 1998; 51: 602–606.Maceratesi P., Daude N., Dallapiccola B. et al. Human UDP9galactose 49prime epimerase (GALE) gene and identification of five missense mutations in patients with epimerase9deficiency galactosemia. Molec. Genet. Metab. 1998; 51: 602–606.Misumi H., Wada H., Kawakami M. et al. Detection of UDP9 galactose 4 epimerase deficiency in a galactosemia screening program. Clin. Chim. Acta. 1981; 116 (1): 101–105.Misumi H., Wada H., Kawakami M. et al. Detection of UDP9 galactose 4 epimerase deficiency in a galactosemia screening program. Clin. Chim. Acta. 1981; 116 (1): 101–105.Openo K.K., Schulz J.M., Vargas C.A. et al. Epimerase9deficiency galactosemia is not a binary condition. Am. J. Hum. Genet. 2006; 68: 89–102.Openo K.K., Schulz J.M., Vargas C.A. et al. Epimerase9deficiency galactosemia is not a binary condition. Am. J. Hum. Genet. 2006; 68: 89–102.Reich S., Hennerman J., Vetter B. An unexpectedly high frequency of hypergalactosemia in an immigrant Bosnian population revealed by newborn screening. Pediatr. Res. 2002; 51: 598–601.Reich S., Hennerman J., Vetter B. An unexpectedly high frequency of hypergalactosemia in an immigrant Bosnian population revealed by newborn screening. Pediatr. Res. 2002; 51: 598–601.Ridel K., Leslie N., Gilbert D. An updated review of the long term neurological effects of galactosemia. Pediatr. Neurol. 2005; 33 (3): 153–161.Ridel K., Leslie N., Gilbert D. An updated review of the long term neurological effects of galactosemia. Pediatr. Neurol. 2005; 33 (3): 153–161.Sangiuolo F., Magnani M., Stambolian D. Biochemical characterization of two GALK1 mutations in patients with galactokinase deficiency. Hum. Mutat. 2004; 23: 396.Sangiuolo F., Magnani M., Stambolian D. Biochemical characterization of two GALK1 mutations in patients with galactokinase deficiency. Hum. Mutat. 2004; 23: 396.Thoden J., Wohlers T., Fridovich9Keil J. et al. Molecular basis for severe epimerase deficiency galactosemia: x-ray structure of the human V94M9substituted UDP galactose 4 epimerase. J. Biol. Chem. 2001; 276: 20617–20623.Thoden J., Wohlers T., Fridovich9Keil J. et al. Molecular basis for severe epimerase deficiency galactosemia: x-ray structure of the human V94M9substituted UDP galactose 4 epimerase. J. Biol. Chem. 2001; 276: 20617–20623.
The authors declare that there are no conflicts of interest present.